Clinical safety of the selective PKC-β inhibitor, ruboxistaurin

Janet B. McGill, George L. King, Paul H. Berg, Karen L. Price, Keri A. Kles, Edward J. Bastyr, David L. Hyslop

Research output: Contribution to journalReview articlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical safety of the selective PKC-β inhibitor, ruboxistaurin'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science